{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:51:48Z","timestamp":1792680708464,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,14]]},"DOI":"10.7759\/cureus.28016","type":"journal-article","created":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T05:27:55Z","timestamp":1660541275000},"source":"Crossref","is-referenced-by-count":8,"title":["Hepatic Encephalopathy and Treatment Modalities: A Review Article"],"prefix":"10.7759","author":[{"given":"Kapil","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivani","family":"Akre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swarupa","family":"Chakole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayur B","family":"Wanjari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.07.013","article-title":"Hepatic encephalopathy: novel insights into classification, pathophysiology and therapy","volume":"73","author":"Rose CF","year":"2020","unstructured":"Rose CF, Amodio P, Bajaj JS, et al.. Hepatic encephalopathy: novel insights into classification, pathophysiology and therapy. J Hepatol. 2020, 73:1526-1547. 10.1016\/j.jhep.2020.07.013","journal-title":"J Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/lt.21593","article-title":"Impact of preoperative overt hepatic encephalopathy on neurocognitive function after liver transplantation","volume":"15","author":"Sotil EU","year":"2009","unstructured":"Sotil EU, Gottstein J, Ayala E, Randolph C, Blei AT. Impact of preoperative overt hepatic encephalopathy on neurocognitive function after liver transplantation. Liver Transpl. 2009, 15:184-192. 10.1002\/lt.21593","journal-title":"Liver Transpl"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.10.004","article-title":"Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF)","volume":"60","author":"Cordoba J","year":"2014","unstructured":"Cordoba J, Ventura-Cots M, Sim\u00f3n-Talero M, et al.. Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF). J Hepatol. 2014, 60:275-281. 10.1016\/j.jhep.2013.10.004","journal-title":"J Hepatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1023\/a:1011614528751","article-title":"Neurotransmitter dysfunction in hepatic encephalopathy: new approaches and new findings","volume":"16","author":"Butterworth RF","year":"2001","unstructured":"Butterworth RF. Neurotransmitter dysfunction in hepatic encephalopathy: new approaches and new findings. Metab Brain Dis. 2001, 16:55-65. 10.1023\/a:1011614528751","journal-title":"Metab Brain Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/gastro\/gox013","article-title":"Hepatic encephalopathy","volume":"5","author":"Ferenci P","year":"2017","unstructured":"Ferenci P. Hepatic encephalopathy. Gastroenterol Rep (Oxf). 2017, 5:138-147. 10.1093\/gastro\/gox013","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/7628522","article-title":"Long noncoding RNAs regulate hyperammonemia-induced neuronal damage in hepatic encephalopathy","volume":"2022","author":"Cheon SY","year":"2022","unstructured":"Cheon SY, Jo D, Kim YK, Song J. Long noncoding RNAs regulate hyperammonemia-induced neuronal damage in hepatic encephalopathy. Oxid Med Cell Longev. 2022, 2022:7628522. 10.1155\/2022\/7628522","journal-title":"Oxid Med Cell Longev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2013.03.010","article-title":"Osmotic and oxidative\/nitrosative stress in ammonia toxicity and hepatic encephalopathy","volume":"536","author":"G\u00f6rg B","year":"2013","unstructured":"G\u00f6rg B, Schliess F, H\u00e4ussinger D. Osmotic and oxidative\/nitrosative stress in ammonia toxicity and hepatic encephalopathy. Arch Biochem Biophys. 2013, 536:158-163. 10.1016\/j.abb.2013.03.010","journal-title":"Arch Biochem Biophys"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.08.021","article-title":"Impaired brain glymphatic flow in experimental hepatic encephalopathy","volume":"70","author":"Hadjihambi A","year":"2019","unstructured":"Hadjihambi A, Harrison IF, Costas-Rodr\u00edguez M, et al.. Impaired brain glymphatic flow in experimental hepatic encephalopathy. J Hepatol. 2019, 70:40-49. 10.1016\/j.jhep.2018.08.021","journal-title":"J Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00018.2001","article-title":"Free radicals in the physiological control of cell function","volume":"82","author":"Dr\u00f6ge W","year":"2002","unstructured":"Dr\u00f6ge W. Free radicals in the physiological control of cell function. Physiol Rev. 2002, 82:47-95. 10.1152\/physrev.00018.2001","journal-title":"Physiol Rev"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.07.046","article-title":"Cerebrospinal fluid metabolomics highlights dysregulation of energy metabolism in overt hepatic encephalopathy","volume":"65","author":"Weiss N","year":"2016","unstructured":"Weiss N, Barbier Saint Hilaire P, Colsch B, et al.. Cerebrospinal fluid metabolomics highlights dysregulation of energy metabolism in overt hepatic encephalopathy. J Hepatol. 2016, 65:1120-1130. 10.1016\/j.jhep.2016.07.046","journal-title":"J Hepatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23367","article-title":"Ammonia and the neutrophil in the pathogenesis of hepatic encephalopathy in cirrhosis","volume":"51","author":"Shawcross DL","year":"2010","unstructured":"Shawcross DL, Shabbir SS, Taylor NJ, Hughes RD. Ammonia and the neutrophil in the pathogenesis of hepatic encephalopathy in cirrhosis. Hepatology. 2010, 51:1062-1069. 10.1002\/hep.23367","journal-title":"Hepatology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70457-9","article-title":"Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction","volume":"117","author":"Rose C","year":"1999","unstructured":"Rose C, Butterworth RF, Zayed J, et al.. Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction. Gastroenterology. 1999, 117:640-644. 10.1016\/S0016-5085(99)70457-9","journal-title":"Gastroenterology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S0079-6123(01)32081-2","article-title":"Neuron-astrocyte cross-talk during synaptic transmission: physiological and neuropathological implications","volume":"132","author":"Bezzi P","year":"2001","unstructured":"Bezzi P, Domercq M, Vesce S, et al.. Neuron-astrocyte cross-talk during synaptic transmission: physiological and neuropathological implications. Progr Brain Res. 2001, 132:255-265. 10.1016\/S0079-6123(01)32081-2","journal-title":"Progr Brain Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2013.03.016","article-title":"Inflammation and hepatic encephalopathy","volume":"536","author":"Coltart I","year":"2013","unstructured":"Coltart I, Tranah TH, Shawcross DL. Inflammation and hepatic encephalopathy. Arch Biochem Biophys. 2013, 536:189-196. 10.1016\/j.abb.2013.03.016","journal-title":"Arch Biochem Biophys"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28598","article-title":"Nonabsorbable disaccharides for hepatic encephalopathy: a systematic review and meta-analysis","volume":"64","author":"Gluud LL","year":"2016","unstructured":"Gluud LL, Vilstrup H, Morgan MY. Nonabsorbable disaccharides for hepatic encephalopathy: a systematic review and meta-analysis. Hepatology. 2016, 64:908-922. 10.1002\/hep.28598","journal-title":"Hepatology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-1989-8_13","article-title":"Neomycin reduces the intestinal production of ammonia from glutamine","volume":"368","author":"Hawkins RA","year":"1994","unstructured":"Hawkins RA, Jessy J, Mans AM, Chedid A, DeJoseph MR. Neomycin reduces the intestinal production of ammonia from glutamine. Adv Exp Med Biol. 1994, 368:125-134. 10.1007\/978-1-4615-1989-8_13","journal-title":"Adv Exp Med Biol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2013.12.021","article-title":"Rifaximin is safe and well tolerated for long-term maintenance of remission from overt hepatic encephalopathy","volume":"12","author":"Mullen KD","year":"2014","unstructured":"Mullen KD, Sanyal AJ, Bass NM, et al.. Rifaximin is safe and well tolerated for long-term maintenance of remission from overt hepatic encephalopathy. Clin Gastroenterol Hepatol. 2014, 12:1390.e2-1397.e2. 10.1016\/j.cgh.2013.12.021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13435","article-title":"Review article: potential mechanisms of action of rifaximin in the management of hepatic encephalopathy and other complications of cirrhosis","volume":"43","author":"Bajaj JS","year":"2016","unstructured":"Bajaj JS. Review article: potential mechanisms of action of rifaximin in the management of hepatic encephalopathy and other complications of cirrhosis. Aliment Pharmacol Ther. 2016, 43:11-26. 10.1111\/apt.13435","journal-title":"Aliment Pharmacol Ther"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1R146","article-title":"Combination therapy for the treatment and prevention of hepatic encephalopathy","volume":"46","author":"Mohammad RA","year":"2012","unstructured":"Mohammad RA, Regal RE, Alaniz C. Combination therapy for the treatment and prevention of hepatic encephalopathy. Ann Pharmacother. 2012, 46:1559-1563. 10.1345\/aph.1R146","journal-title":"Ann Pharmacother"},{"key":"ref20","article-title":"The effect of L-ornithine L-aspartate and branch chain amino acids on encephalopathy and nutritional status in liver cirrhosis with malnutrition","volume":"43","author":"Ndraha S","year":"2011","unstructured":"Ndraha S, Hasan I, Simadibrata M. The effect of L-ornithine L-aspartate and branch chain amino acids on encephalopathy and nutritional status in liver cirrhosis with malnutrition. Acta Med Indones. 2011, 43:6.","journal-title":"Acta Med Indones"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.12142","article-title":"l-ornithine-l-aspartate for hepatic encephalopathy in patients with cirrhosis: a meta-analysis of randomized controlled trials","volume":"28","author":"Bai M","year":"2013","unstructured":"Bai M, Yang Z, Qi X, Fan D, Han G. l-ornithine-l-aspartate for hepatic encephalopathy in patients with cirrhosis: a meta-analysis of randomized controlled trials. J Gastroenterol Hepatol. 2013, 28:783-792. 10.1111\/jgh.12142","journal-title":"J Gastroenterol Hepatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199908053410603","article-title":"Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"341","author":"Sort P","year":"1999","unstructured":"Sort P, Navasa M, Arroyo V, et al.. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med. 1999, 341:403-409. 10.1056\/NEJM199908053410603","journal-title":"N Engl J Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003044.pub2","article-title":"Nonabsorbable disaccharides for hepatic encephalopathy","author":"Als-Nielsen B","year":"2004","unstructured":"Als-Nielsen B, Gluud LL, Gluud C. Nonabsorbable disaccharides for hepatic encephalopathy. Cochr Datab Syst Rev. 2004, CD003044. 10.1002\/14651858.CD003044.pub2","journal-title":"Cochr Datab Syst Rev"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/106782-hepatic-encephalopathy-and-treatment-modalities-a-review-article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:47:59Z","timestamp":1707508079000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/106782-hepatic-encephalopathy-and-treatment-modalities-a-review-article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,14]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.28016","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,14]]}}}